Novo Nordisk Annual General Meeting 2024 Minutes

Official minutes from Novo Nordisk's 2024 Annual General Meeting held on March 21, documenting shareholder votes on board elections, remuneration policies, and capital authorization. The meeting covered company performance, supply chain investments exceeding DKK 75 billion, and strategic initiatives in GLP-1 therapies, obesity treatment, and renewable energy transition toward net-zero 2045 goals.